TARGETINGONE
LIVE

Serial Number

79343943

Owner

TargetingOne Corporation

Attorney

NAZLY AILEEN BAYRAMOGLU

Filing Date

Apr 2, 2022

Add to watchlist:

No watchlists yet
View on USPTO

TARGETINGONE Trademark

Serial Number: 79343943 • Registration: 7601773

TARGETINGONE is a trademark filed by TargetingOne Corporation on April 2, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

TargetingOne Corporation

Room 405, 4th Floor, Building 6,

Entity Type: 03

Trademark Details

Filing Date

April 2, 2022

Registration Date

December 17, 2024

Published for Opposition

August 20, 2024

Goods & Services

Chemical reagents for medical or veterinary purposes; diagnostic biomarker reagents for medical purposes; chemical reagents used for rapid extraction of nucleic acids from biological samples; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, for detecting and treating infectious diseases, hereditary diseases, leukemia, and cancer; diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions; medical diagnostic test strips for blood analysis, urine analysis, saliva analysis; salts for medical purposes; preparations of microorganisms for medical purposes; biological preparations for the treatment of cancer; diagnostic preparations for medical purposes

Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; sample preparation device for medical diagnostic use; medical apparatus used for rapid extraction, purification and separation of nucleic acid from samples; polymerase chain reaction (PCR) analyzing apparatus for medical purposes; medical diagnostic instruments for the analysis of body fluids; polymerase chain reaction (PCR) testing apparatus for medical purposes; immunochemical medical diagnostic testing apparatus for detecting and measuring antibody levels; blood testing apparatus; inhalers for medical use; insufflators for medical use; cases fitted for medical instruments; surgical apparatus and instruments; probes for medical purposes; medical diagnostic apparatus for testing DNA and RNA samples; medical diagnostic apparatus for testing for viruses; medical diagnostic apparatus for detecting cancer; medical diagnostic apparatus for testing cancer cells and DNA, incorporating recorded operating system software

Measuring apparatus, namely, electronic devices used for the qualitative measurement of virus neutralizing antibodies in human serum, plasma and whole blood for laboratory or research purposes; scientific apparatus, namely, polymerase chain reaction (PCR) analyzer for measuring relative DNA, RNA and protein; scientific apparatus and instruments for measuring relative DNA, RNA and protein and parts and fittings therefor; surveying apparatus; surveying instruments; precision measuring apparatus, namely, electronic devices used for the qualitative measurement of virus neutralizing antibodies in human serum, plasma and whole blood for laboratory or research purposes; measuring instruments, namely, electronic devices used for the qualitative measurement of virus neutralizing antibodies in human serum, plasma and whole blood for laboratory or research purposes; computer software applications, downloadable, for use in medical diagnostic fields; downloadable computer software for application and database integration; diagnostic apparatus for the detection of pathogens for laboratory or research use; medical laboratory research instruments for detecting pathogens and DNA analysis; optical inspection apparatus; sample preparation devices for laboratory or research purposes; scientific apparatus and instruments for extracting, purifying and separating nucleic acid for laboratory or research purposes; technical measuring and testing apparatus and instruments for measuring, testing and checking the temperature, pressure, quantity and concentration of gas and liquids; polymerase chain reaction (PCR) testing apparatus for laboratory or research purpose

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Feb 12, 2026 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 6, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 19, 2025 FICS
FINAL DISPOSITION PROCESSED
May 19, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 17, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 17, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 17, 2024 R.PR
TTAB RELEASE CASE TO TRADEMARKS
Nov 22, 2024 TMBN
OPPOSITION TERMINATED NO. 999999
Nov 22, 2024 OP.T
OPPOSITION SUSTAINED NO. 999999
Nov 22, 2024 OP.S
REFUSAL PROCESSED BY IB
Sep 20, 2024 RFNP
OPPOSITION INSTITUTED NO. 999999
Aug 23, 2024 OP.I
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Aug 22, 2024 OPNS
OPPOSITION NOTICE (IB REFUSAL) CREATED
Aug 22, 2024 OPNC
OPPOSITION PAPERS RECEIVED AT TTAB
Aug 21, 2024 OPPF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 20, 2024 NPUB
PUBLISHED FOR OPPOSITION
Aug 20, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 31, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 12, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 9, 2024 XAEC
ASSIGNED TO LIE
Jul 9, 2024 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 3, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 3, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 3, 2024 CNEA
REFUSAL PROCESSED BY IB
Jan 22, 2024 RFNP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Dec 25, 2023 OPNX
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 15, 2023 GNRN
NON-FINAL ACTION E-MAILED
Dec 15, 2023 GNRT
NON-FINAL ACTION WRITTEN
Dec 15, 2023 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Dec 8, 2023 ZZZX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 6, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Dec 6, 2023 OPNR
WITHDRAWN FROM PUB - OG REVIEW QUERY
Nov 7, 2023 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 26, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 26, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 25, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 25, 2023 TROA
REFUSAL PROCESSED BY IB
Apr 13, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 23, 2023 RFCS
REFUSAL PROCESSED BY MPU
Mar 23, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 28, 2023 RFCR
NON-FINAL ACTION WRITTEN
Jan 27, 2023 CNRT
ASSIGNED TO EXAMINER
Jan 19, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 5, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 1, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 30, 2022 REPR